Compound Report Overview
Compound Name:
RISPERIDONE
Compound Identifier:
700756
Mol Structure 2D:
700756
Molecular Weight:
410
Formula:
C23 H27 F N4 O2
Development Status:
US FDA Approved
SMILES:
Cc1nc2CCCCn2c(=O)c1CCN3CCC(CC3)c4noc5cc(F)ccc45
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| RISPERIDONE | 205 | Serotonin 5-HT2B | View |
| RISPERIDONE | 85 | Adrenergic alpha2B | View |
| RISPERIDONE | 86 | Adrenergic alpha2C | View |
| RISPERIDONE | 148 | Histamine H2 | View |
| RISPERIDONE | 80 | Adrenergic alpha1A | View |
| RISPERIDONE | 84 | Adrenergic alpha2A | View |
| RISPERIDONE | 81 | Adrenergic alpha1B | View |
| RISPERIDONE | 82 | Adrenergic alpha1D | View |
| RISPERIDONE | 116 | Dopamine D3 | View |
| RISPERIDONE | 206 | Serotonin 5-HT2C | View |
| RISPERIDONE | 204 | Serotonin 5-HT2A | View |
| RISPERIDONE | 200 | Serotonin 5-HT1A | View |
| RISPERIDONE | 113 | Dopamine D1 | View |
| RISPERIDONE | 114 | Dopamine D2L | View |
| RISPERIDONE | 151 | Imidazoline I2, Central | View |
| RISPERIDONE | 208 | Serotonin 5-HT4 | View |
| RISPERIDONE | 216 | Sodium Channel, Site 2 | View |
| RISPERIDONE | 2 | Acetylcholinesterase | View |
| RISPERIDONE | 121 | Dopamine Transporter | View |
| RISPERIDONE | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| RISPERIDONE | 138 | Glutamate, AMPA | View |
| RISPERIDONE | 695 | Potassium Channel HERG | View |
| RISPERIDONE | 643 | CYP450-2D6 Inhibition | View |
| RISPERIDONE | 214 | Sigma2 | View |
| RISPERIDONE | 626 | Histamine H1, Central | View |
| RISPERIDONE | 181 | Opiate delta | View |
| RISPERIDONE | 213 | Sigma1 | View |
| RISPERIDONE | 117 | Dopamine D4.2 | View |
| RISPERIDONE | 212 | Serotonin Transporter | View |
| RISPERIDONE | 210 | Serotonin 5-HT6 | View |